Gaining the trust and confidence of women is more important than ever in encouraging health screenings. To support radiologists and imaging centers with better tools to do their best work for Women’s’ Health, CureMetrix will be featuring the best in Artificial Intelligence (AI) at SBI 2022. Setup a Meeting Now
Presentations include:
TUESDAY, MAY 17 at 12:15PM EDT
PRODUCT THEATER STAGE
Extending the use of the mammogram and creating more value for the radiologist, this discussion will review new and national research on the evolution of the AI-based Mammogram. Discussion will include an overview of how stratifying the risk of Coronary Heart Disease (CHD) by detecting and quantifying Breast Arterial Calcifications (BAC) can benefit imaging centers, healthcare systems, and millions of women.
Presenters:
KEVIN HARRIS, President and Co-Founder CureMetrix.
ALYSSA WATANABE, MD, FACR, Chief Medical Officer CureMetrix
WEDNESDAY, MAY 18 AT 1:30 PM EDT
HIGH PERFORMANCE OF AI-BASED MODEL FOR SCORING BAC ON MAMMOGRAMS
Artificial intelligence (AI) has impacted all areas of our industry: reducing reading time, increasing cancer detection, and reducing false positives. And now, AI is also bringing clinicians and specialties together to extend the value of radiology to address the #1 killer of women, heart disease.
In this study, Dr. Nerlekar, cardiologist and cardiac imaging specialist, and Dr. Watanabe, radiologist will review the results from an assessment of the external validity of a novel Breast Arterial Calcification (BAC) quantification score using CureMetrix cmAngio™
Presenters:
NITESH NERLEKAR, MD, MPH, PhD
Cardiologist and Cardiac Imaging Specialist
MonashHeart & MonashHealth
Baker Heart & Diabetes Institute
ALYSSA WATANABE, MD, FACR – Radiologist
Chief Medical Officer, CureMetrix
Request a meeting now to arrange an SBI in-person demonstration with CureMetrix
The first FDA-cleared AI-based triage solution for mammography in the U.S. Enables radiologists to triage, sort, and prioritize mammography worklists based on suspicious cases that may need immediate attention.
AI-based CAD intended to identify, mark and score regions of interest on screening and diagnostic mammograms – an investigational SaaS.
An AI-based solution for mammography intended to automate the classification of breast density accurately, consistently, and quickly with a high level of confidence – investigational.
Artificial intelligence-based software intended to help doctors find, score, and assess a woman’s risk of coronary heart disease (CHD) from the same mammogram used to identify breast cancer – investigational.
